Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients
Abstract Background FIGHTDIGO study showed the feasibility and acceptability of handgrip strength (HGS) measure in routine in 201 consecutive patients with digestive cancer treated with ambulatory chemotherapy. The present study focuses on the second aim of FIGHTDIGO study: the relationships between...
Main Authors: | Damien Botsen, Marie-Amélie Ordan, Coralie Barbe, Camille Mazza, Marine Perrier, Johanna Moreau, Mathilde Brasseur, Yohann Renard, Barbara Taillière, Florian Slimano, Eric Bertin, Olivier Bouché |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-4860-1 |
Similar Items
-
Correlation between muscle mass and handgrip strength in digestive cancer patients undergoing chemotherapy
by: Johanna Moreau, et al.
Published: (2019-07-01) -
High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study
by: Hiroyasu Mori, et al.
Published: (2021-06-01) -
Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases
by: Hiroki Nishikawa, et al.
Published: (2021-07-01) -
Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
by: Hiroyasu Mori, et al.
Published: (2019-09-01) -
Physical function‐derived cut‐points for the diagnosis of sarcopenia and dynapenia from the Canadian longitudinal study on aging
by: Anne‐Julie Tessier, et al.
Published: (2019-10-01)